Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Many Korean patients with hair loss, skin allergies, and psoriasis use alternative medicine, but satisfaction is low.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Finasteride reverses early hair loss and promotes growth.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

DHT stops hair regrowth in mice, similar to human hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Hair thickness matters more than density for baldness in Japanese men over 25.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Early balding at 40 increases prostate cancer risk.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

iL-PRF treatment improves hair growth for androgenetic alopecia.